Quadrature Capital LTD Becton Dickinson & CO Transaction History

Quadrature Capital LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $801,249 - $876,365	-3,560 Reduced 19.75%	14,468 $3.38 Billion
Q1 2024 May 14, 2024	BUY	$233.45 - $247.73 $4.21 Million - $4.47 Million	18,028 New	18,028 $4.46 Billion
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $16.8 Million - $19.3 Million	72,346 New	72,346 $17.6 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $599,543 - $676,903	2,610 New	2,610 $646,000
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $4.96 Million - $5.82 Million	21,132 New	21,132 $5.21 Million
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $1.37 Million - $1.52 Million	-5,624 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $1.29 Million - $1.41 Million	5,624 New	5,624 $1.41 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $8.17 Million - $9.01 Million	-35,123 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $6.3 Million - $6.9 Million	27,099 Added 337.72%	35,123 $8.54 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $3.47 Million - $3.84 Million	-14,968 Reduced 65.1%	8,024 $1.95 Million
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $68,795 - $76,241	-310 Reduced 1.33%	22,992 $5.76 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $4.16 Million - $5.34 Million	19,283 Added 479.8%	23,302 $5.29 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $1.41 Million - $1.78 Million	-6,886 Reduced 63.15%	4,019 $883,000
Q3 2018 Nov 13, 2018	BUY	$233.07 - $256.0 $2.54 Million - $2.79 Million	10,905 New	10,905 $0

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.